Linked Life Data

1577666

Source:http://linkedlifedata.com/resource/pubmed/id/1577666

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1992-6-9
pubmed:abstractText
New 3'-deamino-3'-hydroxy-2'-iodoesorubicin analogues were synthesized using optically active 4,6-dideoxyhex-1-enitol (7) as starting material. Direct coupling of daunomycinone (8) and 14-O-tert-butyldimethylsilyladriamycinone (9) with glycal 7 in the presence of N-iodosuccinimide gave 2'-iodo analogues 10 and 12. Deprotection of compounds 10 and 12 led to compounds 11 and 14, the 2'-iodinated, fully unblocked 4'-deoxy-3'-hydroxy congeners of daunorubicin (2) and doxorubicin (1). 2'-Iodo-3'-hydroxyesorubicin (14) showed cytotoxic activity similar to that of doxorubicin in vitro and higher antitumor activity against L-1210 leukemia than doxorubicin in vivo.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0021-8820
pubmed:author
pubmed:issnType
Print
pubmed:volume
45
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
386-93
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed:year
1992
pubmed:articleTitle
3'-Hydroxyesorubicin halogenated at C-2'.
pubmed:affiliation
University of Texas M. D. Anderson Cancer Center, Houston 77030.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't